KYVERNA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.5 USD | +5.95% |
|
+13.55% | 0.00% |
| May. 14 | Kyverna Therapeutics Q1 Loss Narrows | MT |
| Apr. 25 | Nasdaq's revenue beats on strong demand for fintech products | RE |
Chart calendar Kyverna Therapeutics, Inc.
189a66642fec72dc5.cDXxXF-SiRCLCQgGKMSBl9gY0eQSyR1d5-gcD75MsUU.NkGFLivX-z3Cb2Jef7z0oO13hbdEhnYt3r1YfPgh1HEjA9woC8u5edpqTQ~390b059ceb7520bfcb62d03e0e0e4030
Upcoming events on Kyverna Therapeutics, Inc.
No events available
Past events on Kyverna Therapeutics, Inc.
| 2024-04-16 08:45 am | American Academy of Neurology Meeting |
| 2024-03-26 04:05 pm | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 15,0 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -60,7 -63,9 4.94% | -145 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -62,4 -61,8 -1.04% | -148 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -60,4 -62,2 2.96% | -130 |
|
Net income Million USD | Released Forecast Spread | -28,9 | -60,4 -63,1 4.32% | -130 |
|
EPS USD | Released Forecast Spread | -13,9 | -89,6 -22,1 -305.3% | -3,65 |
| Announcement Date | 05/10/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -20,9 -25,0 16.34% | -36,0 | -44,0 | -51,0 | |
|
EBIT Million USD | Released Forecast Spread | -21,4 -23,0 7.06% | -29,4 -32,0 8.26% | -36,0 | -44,0 | -51,0 |
|
EPS USD | Released Forecast Spread | -75,8 -8,35 -808.18% | -1,12 -1,12 0% | -0,79 | -0,88 | -1,00 |
| Announcement Date | 26/03/24 | 14/05/24 | - | - | - |
| 2024-05-15 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for Kyverna Therapeutics, Inc.
| Today | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-13 | BELITE BIO, INC: Q1 2024 Earnings Release |
| 2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
| 2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-12 07:00 pm | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
| 2024-05-13 06:30 am | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-13 04:10 pm | CENTESSA PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 2024-05-12 | BIOMEA FUSION, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KYTX Stock
- Calendar Kyverna Therapeutics, Inc.